Sort
23,748 grants matching “melanoma”
Optimized IL2-based Therapy for Type 1 Diabetes
$298,486Ridong Chen · Apt Therapeutics, Inc. · R43 · FY2015 · DK
Cancer cell telomere dynamics and responses to perturbations
$298,479Elizabeth H Blackburn · University Of California, San Francisco · R01 · FY2009 · CA
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
$298,443Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
$298,443Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA
Tumor Stroma Interactions: Wound Promoted Tumor Growth
$298,403John Niederhuber · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanistic Studies on New Platinum Clinical Agents
$298,321Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2006 · CA
Photonic Nanosonophores for Functional and Structural Imaging
$298,304Raoul Kopelman · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Structural Studies of Bacterial Architecture Using Electron Tomography
$298,293Jacqueline Milne · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Dendritic Cell-Based Genetic Immunotherapy for Melanoma
$298,269University Of California Los Angeles · R01 · FY2003 · CA
SBIR PHASE I-RADIONUCLIDE THERAPY FOR METASTATIC MELANOMA VIEWPOINT MOLECULAR TARGETING, LLC:1256544 [15-068338] IGF::OT::IGF
$298,184Michael Schultz · Viewpoint Molecular Targeting, Inc. · N43 · FY2015 · CA
Single Cell Genomics Core
$298,153Michael L Whitfield · Dartmouth College · P20 · FY2020 · GM
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in
$298,054David John Hunter · Brigham And Women'S Hospital · P50 · FY2011 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES
$298,035University Of California Irvine · R01 · FY2004 · CA
Core 3: Rexinoid Screening and Animal Core
$297,974Mohammad Athar · University Of Alabama At Birmingham · P01 · FY2020 · CA
Discovery of Novel Thiazole Analogs for Treating Malignant Melanoma
$297,887Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2014 · CA
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
$297,867Traci A Wilgus · University Of Illinois At Chicago · R01 · FY2007 · CA
Mda-5: Novel Apoptosis Inducing Gene
$297,850Columbia University Health Sciences · R01 · FY2005 · GM
Mda-5: Novel Apoptosis Inducing Gene
$297,850Columbia University Health Sciences · R01 · FY2004 · GM
ADHESION AND ERK SIGNALING IN MELANOMA
$297,794Andrew E Aplin · Thomas Jefferson University · R01 · FY2010 · GM
BONE MARROW DERIVED FIBROBLASTS AND THEIR ROLE IN TISSUE REPAIR AND FIBROSIS
$297,790Mehrdad Abedi · Roger Williams Hospital · P20 · FY2009 · RR
New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling Pathways
$297,744W. Andy Tao · Purdue University · R01 · FY2011 · GM
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities
$297,705Brent Allen Hanks · Duke University · R01 · FY2023 · CA
Impact of AICD on TCR Transduced T Cells for Adoptive Immunotherapy
$297,679Jose Alejandro Guevara-Patino · Loyola University Chicago · P01 · FY2012 · CA
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo
$297,619Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2013 · CA
Survival Mechanisms of Invasive Carcinoma Cells
$297,592Richard L. Klemke · University Of California, San Diego · R01 · FY2010 · CA